On June 8, 2017, SIAPS disseminated the Directorate General of Drug Administration’s (DGDA) five-year Strategic Plan (2017-2021) in the presence of the Honorable Major General Mohammad Mustafizur Rahman, Director General of DGDA. The dissemination of this plan is the result of a year-long process. In March 2016, WHO engaged with various stakeholders (SIAPS, USAID, the […]
Archive | Policies and Strategic PlansRSS feed for this section
A new collection of technical briefs highlight strategic approaches, innovations, results and lessons learned in implementing systems-wide interventions to strengthen pharmaceutical systems and services in three countries: South Africa, Namibia and Ethiopia. Click on the thumbnails below to read the full technical briefs. Strengthening Namibia’s Pharmacy Sector and Workforce Strengthening the Leadership and Management of […]
Developing a CMS strategic plan can help align pharmaceutical supply chain objectives with overall public-sector health supply chain strategies. It can help ensure that health commodities are readily available to health facilities through an uninterrupted supply chain; minimize waste and losses; improve business and financial growth; and respond to changes in the supply chain, such as new technologies and emerging markets. In addition, advocating for and encouraging stakeholders to assess the medicine supply chain system can increase interest in generating additional technical, financial, and material resources for health care. Supply chain interventions can also contribute to improving rational medicine use and strengthening pharmaceutical regulation.
Systems thinking is now a widely accepted concept in global health. Governments, donors, and other actors in global health recognize that guaranteeing the availability of medicines is a necessary, but insufficient component to improving health outcomes. Rather, medicines availability must be bolstered by other components, such as ensuring that quality medicines are available and prescribed and dispensed appropriately by health care workers; patients must also use medicines properly. In order to achieve improvements in health for their populations and address health inequities, governments and donors must invest in strengthening health systems. A health system depends on its subcomponent, a pharmaceutical system, for the continuous availability of safe, effective, and affordable essential medicines and other health technologies of assured quality to deliver effective health interventions that improve health outcomes. This is in alignment with USAID’s Vision for Health Systems Strengthening (2015-2019). To this end, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program focuses on achieving positive health outcomes by assuring the availability of quality pharmaceutical products and effective pharmaceutical services.
Technical Approach to Developing a Strategic Plan to Strengthen the Central Medical Store: The Case of Pharmacie Populaire du Mali
This document describes the techniques and experiences of and lessons learned from developing a strategic plan for the Pharmacie Populaire du Mali (PPM). Technical assistance providers, managers of pharmaceutical supply chain organizations, and consultants can adapt this information to suit local contexts and needs and apply it to their own public health pharmaceutical supply chain strategic plans.
SIAPS employed a systematic and structured approach to support PPM in developing its first strategic plan, including defining the scope and refining the task of developing a strategic plan through consultation with key stakeholders; conducting a national supply chain situational analysis that included country context–political, environmental, social, legislative, economic, and ethical factors–identifying gaps between the organization’s mission and vision and the expectations of clients and stakeholders; prioritizing and developing strategic objectives; and action planning and budgeting.
Global partnerships and new models of TB care are crucial to success in the fight against multidrug-resistant tuberculosis (MDR-TB), according to speakers at a panel discussion on the White House National Action Plan for Combating MDR-TB. The plan, which was released in December, aims to treat 35% of all MDR-TB patients in the 10 countries with the highest TB burden […]
From the development of sound policies and legislation, to the selection, procurement, and distribution of medicines; governance issues permeate all levels of the pharmaceutical sector and heavily influence the availability and accessibility of medicines and other health commodities. The USAID-funded SIAPS project is pleased to announce the launch of a new course on USAID’s Global Health […]
On June 30th the Haitian Ministry of Public Health and Population (MSPP) launched the country’s first National Medicines Policy (NMP) in Port-au-Prince. The policy, developed by the Haitian MSPP with the support of SIAPS Program, establishes a framework for pharmaceutical regulation in the country. The launch was chaired by Haitian Prime Minister Evans Paul and […]
Improving the availability and accessibility of safe, and affordable quality essential medicines is crucial to fighting common diseases and improving public health around the world. The establishment of national policies that clearly lay out legal and administrative terms for the pharmacy sector, strengthen the national medicine supply system, and promote the rational use of medicines […]
Rising to the Challenge: Developing the Pharmaceutical Leadership Development Program (PLDP) in South Africa
Strong leadership and management have been recognised as important factors in the efficient use of resources, the delivery of quality health services, and the achievement of positive health outcomes. Against this backdrop, the Committee of Heads of Pharmaceutical Services in South Africa identified the need to develop and strengthen leadership and management skills among pharmacists, […]